Qiming GP VIII-HC, LLC — SEC insider filings

SEC reporting owner CIK 2129671. 9 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 9 filings on record, filed 2026-04-22 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Alamar Biosciences, Inc. (ALMR)10% owner9—128 legs · 1,599,066 sh · $47,502,97620

Insider filings — Qiming GP VIII-HC, LLC

FiledFormIssuerReported transactionsSource
2026-11-134Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 1,694 @ $29.34 · Sale (S): 56 @ $30.63 · Sale (S): 62,944 @ $29.34 · Sale (S): 2,084 @ $30.63 · Sale (S): 14,687 @ $29.34 · Sale (S): 486 @ $30.63 · +2 moreEDGAR
2026-11-054Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 1,946 @ $29.89 · Sale (S): 72,301 @ $29.89 · Sale (S): 16,870 @ $29.89 · Sale (S): 20,196 @ $29.89EDGAR
2026-11-034Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 1,309 @ $29.93 · Sale (S): 1,080 @ $30.70 · Sale (S): 92 @ $31.96 · Sale (S): 31 @ $33.31 · Sale (S): 48,659 @ $29.93 · Sale (S): 40,112 @ $30.70 · +18 moreEDGAR
2026-10-294Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 134 @ $30.33 · Sale (S): 943 @ $31.33 · Sale (S): 408 @ $31.88 · Sale (S): 4,960 @ $30.33 · Sale (S): 35,049 @ $31.33 · Sale (S): 15,131 @ $31.88 · +14 moreEDGAR
2026-10-274Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 107 @ $29.35 · Sale (S): 832 @ $30.23 · Sale (S): 1,646 @ $30.85 · Sale (S): 3,975 @ $29.35 · Sale (S): 30,921 @ $30.23 · Sale (S): 61,191 @ $30.85 · +14 moreEDGAR
2026-10-234Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 592 @ $29.01 · Sale (S): 677 @ $29.75 · Sale (S): 2,380 @ $30.79 · Sale (S): 22,020 @ $29.01 · Sale (S): 25,177 @ $29.75 · Sale (S): 88,434 @ $30.79 · +18 moreEDGAR
2026-10-214Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 1,320 @ $26.34 · Sale (S): 49,044 @ $26.34 · Sale (S): 11,443 @ $26.34 · Sale (S): 13,701 @ $26.34 · Sale (S): 200 @ $26.63 · Sale (S): 1,947 @ $27.93 · +10 moreEDGAR
2026-10-194Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Sale (S): 3,024 @ $27.73 · Sale (S): 9 @ $28.26 · Sale (S): 112,392 @ $27.73 · Sale (S): 325 @ $28.26 · Sale (S): 26,224 @ $27.73 · Sale (S): 76 @ $28.26 · +6 moreEDGAR
2026-04-224Alamar Biosciences, Inc. (ALMR)
jointly with Qiming Corporate GP VI, Ltd., Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming Venture Partners VIII-HC, L.P.
Conversion (C): 185,163 · Conversion (C): 6,881,410 · Conversion (C): 1,605,645 · Conversion (C): 1,922,329 · Other (J): 185,163 · Other (J): 6,881,410 · +14 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2129671 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs